(Q43749611)

26 November 2017

title

Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients (English)

1 reference

26 November 2017

1 reference

Sahar Hossam El-Hini

1

1 reference

26 November 2017

Faten Ismail Mohamed

2

1 reference

26 November 2017

Amel Ali Hassan

3

1 reference

26 November 2017

Fatma Ali

4

1 reference

26 November 2017

Amel Mahmoud

5

1 reference

26 November 2017

Hanaa M Ibraheem

6

1 reference

26 November 2017

publication date

8 March 2013

1 reference

Rheumatology International

26 November 2017

published in

1 reference

26 November 2017

volume

33

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

2283-2289

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-013-2714-3

26 November 2017

exact match

0 references

cites work

Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Insulin resistance and impaired beta cell function in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

The contribution of adipose tissue and adipokines to inflammation in joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Insulin resistance in early untreated rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Adipocytokines and the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Adiponectin and inflammation: consensus and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2714-3

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis and diabetes mellitus: evidence for an association?

1 reference

12 December 2020

Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices

1 reference

12 December 2020

Etanercept increases adiponectin level in woman with rheumatoid arthritis

1 reference

12 December 2020

10.1007/S00296-013-2714-3

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1013120222

0 references

1 reference